Breath Therapeutics nabs Series A funds
Breath Therapeutics, a Germany-based provider of inhalation therapies for severe respiratory diseases, has raised 43.5 million euros in Series A funding. Gimv and Sofinnova Partners led the round.
8 March 2017•5 mins read
